ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Biogen Inc

Biogen Inc (IDP)

136.90
-0.15
(-0.11%)
Closed February 08 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
136.90
Bid
136.40
Ask
137.25
Volume
550
135.65 Day's Range 138.25
0.00 52 Week Range 0.00
Market Cap
Previous Close
137.05
Open
138.05
Last Trade
1
@
137
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
17.74
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker IDP. The last closing price for Biogen was 137.05 €. Over the last year, Biogen shares have traded in a share price range of 0.00 € to 0.00 €.

Biogen currently has 145,719,340 shares outstanding. The market capitalization of Biogen is 19.97 € billion. Biogen has a price to earnings ratio (PE ratio) of 17.74.

IDP Latest News

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo...

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Once every four weeks maintenance dosing may be easier for patients and care partners to...

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher...

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease LEQEMBI is the only FDA-approved anti-amyloid...

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

IDP - Frequently Asked Questions (FAQ)

What is the current Biogen share price?
The current share price of Biogen is 136.90 €
How many Biogen shares are in issue?
Biogen has 145,719,340 shares in issue
What is the market cap of Biogen?
The market capitalisation of Biogen is EUR 19.97B
What is the 1 year trading range for Biogen share price?
Biogen has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Biogen?
The price to earnings ratio of Biogen is 17.74
What is the cash to sales ratio of Biogen?
The cash to sales ratio of Biogen is 2.09
What is the reporting currency for Biogen?
Biogen reports financial results in USD
What is the latest annual turnover for Biogen?
The latest annual turnover of Biogen is USD 9.84B
What is the latest annual profit for Biogen?
The latest annual profit of Biogen is USD 1.16B
What is the registered address of Biogen?
The registered address for Biogen is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Biogen website address?
The website address for Biogen is www.biogen.com
Which industry sector does Biogen operate in?
Biogen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMWChina Communications Services Corp
39.89 €
(7,219.27%)
152
3YBPostal Savings Bank of China
39.55 €
(6,838.60%)
3.7k
1NSSinopec Engineering (Group) Co Ltd
39.715 €
(4,991.67%)
1.8k
M0GFireweed Metals Corp
39.815 €
(3,642.01%)
1.14k
0ZBConverge Technology Solutions Corp
3.656 €
(53.68%)
75.08k
1RR1Rokmaster Resources Corp
0.003 €
(-76.00%)
6k
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
3.69k
POTAPortofino Resources Inc
0.0028 €
(-46.15%)
267.47k
D4GDataMetrex AI Ltd
0.0032 €
(-40.74%)
29.97k
8NI0Nikola Corp
0.4368 €
(-39.78%)
1.85M
M11First Graphene Limited
0.0458 €
(-16.73%)
3.19M
FMKEcograf Limited
0.0788 €
(18.32%)
2.41M
G7PAEnergy Transition Minerals Ltd
0.0492 €
(0.41%)
2.21M
3CPXiaomi Corporation
5.30 €
(5.37%)
2.19M
D7GNel ASA
0.198 €
(1.02%)
2.01M

Discussion

View Full Feed
Wingsjr Wingsjr 5 minutes ago
So if only the 1% got a tax cut, why will all of our taxes go up if the 45 tax cuts expire? How did we have so much more money under 45 than JB? Don’t know what it takes to be in the 1% but since 47 was elected, he has made me 1.9 million in our profit. I hold XRP, FNMA and FMCC. I am a multi millio
FMCC
dinogreeves dinogreeves 6 minutes ago
Hey bud, this is what you need to do, go to Yahoo message board for SMCI and read some the posts there and draw your own conclusion and use some common sense. Usually on that board there are constant messages, sometimes to the tune of 300 viewing, SMCI is one hot ticker. Here is one post from ther
SMCI
doc2016 doc2016 7 minutes ago
imagine the startrek dr mccoy tricorder you could have with sensor and a quantum charged ion device.

given zuckerberg is now saying smart glasses and maybe your smart device in your pocket might be the new way we interact with our environment?
but to get the quantum computer
IONQ
arizona1 arizona1 7 minutes ago
Egypt stepped in offering to rebuild Gaza.

Egypt gets the second most foreign aid money from us. Are you really this stupid? Egypt is a very poor country.

While not considered one of the poorest countries globally, Egypt is classified as a lower-middle-income country,
JJ8 JJ8 7 minutes ago
Just look at the dysfunctional leadership that is totally incompatible for bringing nations together of the world for the good of all it is dealing in trivial pursuits and knocking down standing and reputation of the USA. This is the worst that I have seen in my lifetime. Terrible times.
NVDA
wiwineguy wiwineguy 8 minutes ago
This thing takeover candidate in a couple years
PTLO
gutedogg gutedogg 9 minutes ago
Yessss Sprycel was all in back then lol what happened to him so glad we held out 524 club
TGLO
gutedogg gutedogg 10 minutes ago
Yessss Sprycel was all in back then lol what happened to him so glad we held out 524 club
TGLO
janice shell janice shell 10 minutes ago
Yes. I'm pretty sure about three-quarters of people who preach the virtues of crispy chicken skin end up with the same rubbery stuff we get.

Or they grill it and burn it. I don't have a grill, so I can't experiment with that.
MrMike241 MrMike241 13 minutes ago
Definitely skinless.
JohnnyMakeBucks JohnnyMakeBucks 13 minutes ago
It’s not radio silence. It’s people expecting a pr every week. Then when one comes out the stock gets slammed. I wouldn’t put anything either.
IDVV
Ayock Ayock 15 minutes ago
If you’re a Trump supporter and you see me mocking Trump supporters, let’s be clear—I am talking about you specifically, and yes, I do hope you’re offended. Because you’re an idiot, and you’re actively making this country worse.
brianslate brianslate 15 minutes ago
Well Said!!!! GLTA and looking forward to Monday.
AIAD
Guzzi62 Guzzi62 17 minutes ago
Nope, they are not, not even close.

How many employees? 20?, many in their senior years.

It will take billions of $ getting into the markets & running more trials and lots of fresh young people willing to work many hours every day and not old people sitting in a rocking
NWBO
govprs govprs 20 minutes ago
Man I'm sorry.  Wish you good health 
GALT
carvajal carvajal 21 minutes ago
Thanks, really appreciate the info! Can't reply to dm's bc i'm using ihubs free version.
HMBL
govprs govprs 23 minutes ago
Yep fools believe in garr and fools day lol 
CUBT
layton layton 25 minutes ago
If only the SEC can get to Ron Lowenthal, Alan Santini....They out of reach in South Africa.
GNCP
unlimitedgains4 unlimitedgains4 27 minutes ago
Tzero is a solid platform ps check dm :)
HMBL
dinogreeves dinogreeves 27 minutes ago
This all you need to know, just hope that there are no discrepancy in the audit report, not that there will be sell on the news, who cares people sell on the news, long term horizon is all that matters.

" tell me that Blackrock bought 1.6 billions without having come to the conclusion
SMCI
janice shell janice shell 27 minutes ago
That is very local cooling, and follows on a number of very warm winters. We didn't have any snow for three years in a row, and not much the year before that.

Right now, it is NOT snowing, despite what Weather.com says. Looks like freezing rain. Which is way worse.
Dingbatt Dingbatt 27 minutes ago
Fish
Thankyou I just read the whole thing
The expert board is connected to 9000 wheels in motion through the DTCC you have to be a participant to get into the system Depository Trust I believe bar none is the most powerful entity a corporation in the world its assets dwarf ythe total
GNCP
JusDePomme JusDePomme 28 minutes ago
I will watch the show tomorrow! We shall see how they demonstrate to the world about their technology
AFFU

Your Recent History

Delayed Upgrade Clock